LTR Pharma Limited (ASX:LTP)
Australia · Delayed Price · Currency is AUD 0.4700
+0.0200 (4.44%)
Nov 11, 2026, 4:10 PM AEDT
LTR Pharma Market Cap
LTR Pharma has a market cap or net worth of 85.67 million as of November 10, 2026. It is the 28,675th most valuable company in the world and the 638th biggest in Australia. Its market cap has increased by 0.36% in one year.
Market Cap
85.67M
Enterprise Value
66.01M
Revenue
723.94K
Global Rank
Country Rank
#638 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since December 11, 2023, LTR Pharma's market cap has increased from 52.98M to 85.67M, an increase of 61.70%. That is a compound annual growth rate of 17.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 85.67M | -34.50% |
| Dec 31, 2025 | 130.78M | -10.78% |
| Dec 31, 2024 | 146.59M | 204.77% |
| Dec 29, 2023 | 48.10M | -9.21% |
| Dec 11, 2023 | 52.98M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dimerix | 123.08M |
| Nyrada | 122.56M |
| Recce Pharmaceuticals | 100.90M |
| Island Pharmaceuticals | 96.23M |
| Prescient Therapeutics | 61.77M |
| Alterity Therapeutics | 60.71M |
| Arovella Therapeutics | 60.44M |
| Neurizon Therapeutics | 49.61M |